MedPath

Comparison of the Sodium valproate and Sodae herbal capsule effects on migraine pai

Phase 3
Recruiting
Conditions
migraine.
Migraine
Registration Number
IRCT20200126046272N3
Lead Sponsor
Booali Daroo pharmaceutical company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Having more than 3 attacks per month in the last three months
Having more than 3 attacks at the base time
Start migraines at least one year before entering the project
Start migraines before age 50

Exclusion Criteria

Chronic tension headaches or other headaches for more than 15 days a month
Pregnancy, lactation
Patients should not be addicted to alcohol or other illegal substances

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of migraine. Timepoint: Baseline, Three months after the Baseline. Method of measurement: Based on Headache Disability Scale (MIDAS) and Headache Severity Test (HIT6).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath